Boston Scientific Corporation (Form: 8-K)  






Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):   March 29, 2010

Boston Scientific Corporation
(Exact name of registrant as specified in its charter)

Delaware 1-11083 04-2695240
(State or other jurisdiction
(I.R.S. Employer
of incorporation) File Number) Identification No.)
One Boston Scientific Place, Natick, Massachusetts   01760-1537
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code:   508-650-8000

Not Applicable
Former name or former address, if changed since last report


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Top of the Form

Item 7.01 Regulation FD Disclosure.

Today we are hosting conference calls with physicians to discuss the recent voluntary removal of our high voltage ICD and CRT-D devices and our new Cardiology, Rhythm and Vascular business. A copy of the script for the conference calls is furnished as Exhibit 99.1 hereto.

Item 9.01 Financial Statements and Exhibits.

Exhibit No. 99.1: Script for March 29, 2010 Physician conference calls.

Top of the Form


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Boston Scientific Corporation
March 29, 2010   By:   Lawrence J. Knopf
        Name: Lawrence J. Knopf
        Title: Senior Vice President and Deputy General Counsel

Top of the Form

Exhibit Index

Exhibit No.   Description

  Script for March 29, 2010 Physician Conference Calls